Two functionally distinct α2-adrenergic receptors regulate sympathetic neurotransmission

被引:420
作者
Hein, L
Altman, JD
Kobilka, BK [1 ]
机构
[1] Stanford Univ, Beckman Ctr B157, Howard Hughes Med Inst, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Med, Stanford, CA 94305 USA
[3] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA
[4] Univ Wurzburg, Dept Pharmacol & Toxicol, D-97078 Wurzburg, Germany
关键词
D O I
10.1038/46040
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The sympathetic nervous system regulates cardiovascular function by activating adrenergic receptors in the heart, blood vessels and kidney(1), alpha(2)-Adrenergic receptors are known to have a critical role in regulating neurotransmitter release from sympathetic nerves and from adrenergic neurons in the central nervous system(2-5); however, the individual roles of the three highly homologous alpha(2)-adrenergic-receptor subtypes (alpha(2A), alpha(2B), alpha(2C)) in this process are not known. We have now studied neurotransmitter release in mice in which the genes encoding the three alpha(z)-adrenergic-receptor subtypes were disrupted. Here we show that both the alpha(2A)- and alpha(2C)-subtypes are required for normal presynaptic control of transmitter release from sympathetic nerves in the heart and from central noradrenergic neurons. alpha(2A)-Adrenergic receptors inhibit transmitter release at high stimulation frequencies, whereas the a,c-subtype modulates neurotransmission at lower levels of nerve activity. Both low- and high-frequency regulation seem to be physiologically important, as mice lacking both alpha(2A)- and alpha(2C)-receptor subtypes have elevated plasma noradrenaline concentrations and develop cardiac hypertrophy with decreased left ventricular contractility by four months of age.
引用
收藏
页码:181 / 184
页数:4
相关论文
共 30 条
[1]   Abnormal regulation of the sympathetic nervous system in α2A-adrenergic receptor knockout mice [J].
Altman, JD ;
Trendelenburg, AU ;
Macmillan, L ;
Bernstein, D ;
Limbird, L ;
Starke, K ;
Kobilka, BK ;
Hein, L .
MOLECULAR PHARMACOLOGY, 1999, 56 (01) :154-161
[2]  
BYLUND DB, 1994, PHARMACOL REV, V46, P121
[3]   PLASMA NOREPINEPHRINE AS A GUIDE TO PROGNOSIS IN PATIENTS WITH CHRONIC CONGESTIVE HEART-FAILURE [J].
COHN, JN ;
LEVINE, TB ;
OLIVARI, MT ;
GARBERG, V ;
LURA, D ;
FRANCIS, GS ;
SIMON, AB ;
RECTOR, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (13) :819-823
[4]   Progressive hypertrophy and heart failure in β1-adrenergic receptor transgenic mice [J].
Engelhardt, S ;
Hein, L ;
Wiesmann, F ;
Lohse, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) :7059-7064
[5]   1,1'-diisopropyl-2,4'-cyanine (disprocynium24), a potent uptake(2) blocker, inhibits the renal excretion of catecholamines [J].
Graefe, KH ;
Friedgen, B ;
Wolfel, R ;
Bossle, F ;
Russ, H ;
Schomig, E .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 356 (01) :115-125
[6]   BEHAVIORAL AND CARDIOVASCULAR EFFECTS OF DISRUPTING THE ANGIOTENSIN-II TYPE-2 RECEPTOR GENE IN MICE [J].
HEIN, L ;
BARSH, GS ;
PRATT, RE ;
DZAU, VJ ;
KOBILKA, BK .
NATURE, 1995, 377 (6551) :744-747
[7]   Overexpression of angiotensin AT(1) receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block [J].
Hein, L ;
Stevens, ME ;
Barsh, GS ;
Pratt, RE ;
Kobilka, BK ;
Dzau, VJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (12) :6391-6396
[8]   Substitution of a mutant alpha(2a)-adrenergic receptor via ''hit and run'' gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo [J].
Lakhlani, PP ;
MacMillan, LB ;
Guo, TZ ;
McCool, BA ;
Lovinger, DM ;
Maze, M ;
Limbird, LE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (18) :9950-9955
[9]   25 years since the discovery of presynaptic receptors: Present knowledge and future perspectives [J].
Langer, SZ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1997, 18 (03) :95-99
[10]   Clinical effects of β-adrenergic blockade in chronic heart failure -: A meta-analysis of double-blind, placebo-controlled, randomized trials [J].
Lechat, P ;
Packer, M ;
Chalon, S ;
Cucherat, M ;
Arab, T ;
Boissel, JP .
CIRCULATION, 1998, 98 (12) :1184-1191